Initial Systemic Treatment of Acute GVHD: A Phase II Randomized Trial Evaluating Etanercept, Mycophenolate Mofetil (MMF), Denileukin Diftitox (ONTAK), and Pentostatin in Combination With Corticosteroids (BMT CTN 0302).
Latest Information Update: 29 Dec 2017
At a glance
- Drugs Denileukin diftitox (Primary) ; Etanercept (Primary) ; Mycophenolate mofetil (Primary) ; Mycophenolate mofetil (Primary) ; Pentostatin (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 12 Dec 2017 Results from NCT00224874 and NCT01002742 studies, presented at the 59th Annual Meeting and Exposition of the American Society of Hematology
- 16 May 2011 Actual initiation date changed from Sep 2005 to Aug 2005 as reported by ClinicalTrials.gov (NCT00474149).
- 16 May 2011 Actual initiation date changed from Sep 2005 to Aug 2005 as reported by ClinicalTrials.gov (NCT00474149).